SK280246B6 - Náplasť s účinnou látkou na dávkovanie estradiolu - Google Patents

Náplasť s účinnou látkou na dávkovanie estradiolu Download PDF

Info

Publication number
SK280246B6
SK280246B6 SK1206-95A SK120695A SK280246B6 SK 280246 B6 SK280246 B6 SK 280246B6 SK 120695 A SK120695 A SK 120695A SK 280246 B6 SK280246 B6 SK 280246B6
Authority
SK
Slovakia
Prior art keywords
active substance
estradiol
reservoir
active
patch according
Prior art date
Application number
SK1206-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK120695A3 (en
Inventor
Teresa M. Murphy
Original Assignee
Lohmann Therapie-Systeme Gmbh And Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie-Systeme Gmbh And Co. Kg filed Critical Lohmann Therapie-Systeme Gmbh And Co. Kg
Publication of SK120695A3 publication Critical patent/SK120695A3/sk
Publication of SK280246B6 publication Critical patent/SK280246B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
SK1206-95A 1993-03-26 1994-03-07 Náplasť s účinnou látkou na dávkovanie estradiolu SK280246B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4309830A DE4309830C1 (de) 1993-03-26 1993-03-26 Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
PCT/EP1994/000670 WO1994022481A1 (de) 1993-03-26 1994-03-07 Wirkstoffpflaster für die abgabe von estradiol an die haut

Publications (2)

Publication Number Publication Date
SK120695A3 SK120695A3 (en) 1997-02-05
SK280246B6 true SK280246B6 (sk) 1999-10-08

Family

ID=6483909

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1206-95A SK280246B6 (sk) 1993-03-26 1994-03-07 Náplasť s účinnou látkou na dávkovanie estradiolu

Country Status (23)

Country Link
US (1) US5686098A (pl)
EP (1) EP0689458B1 (pl)
JP (1) JPH08508266A (pl)
KR (1) KR960700754A (pl)
AT (1) ATE173636T1 (pl)
AU (1) AU681383B2 (pl)
CA (1) CA2156746A1 (pl)
CZ (1) CZ287544B6 (pl)
DE (2) DE4309830C1 (pl)
DK (1) DK0689458T3 (pl)
ES (1) ES2127384T3 (pl)
FI (1) FI954497A0 (pl)
GR (1) GR3029387T3 (pl)
HR (1) HRP940213A2 (pl)
HU (1) HU220861B1 (pl)
IL (1) IL109084A (pl)
NO (1) NO953792D0 (pl)
NZ (1) NZ262418A (pl)
PL (1) PL173547B1 (pl)
SK (1) SK280246B6 (pl)
WO (1) WO1994022481A1 (pl)
YU (1) YU14394A (pl)
ZA (1) ZA941987B (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE4429663C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Hydrolyseschutz
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
FR2749586B1 (fr) * 1996-06-11 1998-08-07 Hoechst Marion Roussel Inc Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
DE19702314C2 (de) * 1997-01-23 2000-12-21 Lohmann Therapie Syst Lts Ablösbare Schutzfolie für wirkstoffhaltige, insbesondere selbstklebende Pflastersysteme
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
FR2789586A1 (fr) * 1999-02-16 2000-08-18 Synthelabo Composition pharmaceutique pour administration transmucosale balanique d'alfuzosine
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
FR2869232B1 (fr) * 2004-04-21 2007-09-21 Gattefosse Sas Soc Par Actions Nouveaux excipients pharmaceutiques ou cosmetiques a base d'acetals cyliques
US20060134188A1 (en) * 2004-12-20 2006-06-22 Hans-Peter Podhaisky Transdermal pharmaceutical preparation with a progesterone A-specific ligand (PRASL) as active ingredient
DE102004062182B4 (de) * 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
FR2912149B1 (fr) * 2007-02-05 2012-10-12 Rhodia Poliamida E Especialidades Ltda Utilisation de derives de dioxolane dans des systemes de revetement et formulation de systeme de revetement
CA2696632C (en) * 2007-08-17 2014-05-27 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
DE102008059054A1 (de) * 2008-11-26 2010-05-27 Otto Bock Pur Life Science Gmbh Polyurethanpflaster für die transdermale Applikation von Wirkstoffen und Verfahren zu dessen Herstellung
JP5576523B2 (ja) * 2013-02-22 2014-08-20 ロディア・ポリアミダ・エ・エスペシアリダデス・リミターダ コーティング系におけるジオキソラン誘導体の使用及びコーティング系配合物
JP5639208B2 (ja) * 2013-02-22 2014-12-10 ロディア・ポリアミダ・エ・エスペシアリダデス・リミターダＲｈｏｄｉａ Ｐｏｌｉａｍｉｄａ Ｅ Ｅｓｐｅｃｉａｌｉｄａｄｅｓ Ｌｔｄａ コーティング系におけるジオキソラン誘導体の使用及びコーティング系配合物
CN116157211B (zh) * 2020-08-26 2024-03-08 中国涂料株式会社 低voc涂料组合物、涂膜和具有涂膜的基材以及它们的制造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1385914A (en) * 1971-10-19 1975-03-05 Wigglesworth Ltd Compositions having bactericidal activity
BE795226A (fr) * 1972-02-11 1973-08-09 Syntex Corp Vehicule pour pommade contenant du dimethyl-2,2dioxolane-1,3 methanol-4
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4906169A (en) * 1986-12-29 1990-03-06 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
DE58906975D1 (de) * 1988-08-02 1994-03-24 Ciba Geigy Mehrschichtiges Pflaster.
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system

Also Published As

Publication number Publication date
PL310555A1 (en) 1995-12-27
ZA941987B (en) 1995-04-05
CZ287544B6 (en) 2000-12-13
ES2127384T3 (es) 1999-04-16
WO1994022481A1 (de) 1994-10-13
FI954497A7 (fi) 1995-09-22
NZ262418A (en) 1996-08-27
HUT73425A (en) 1996-07-29
PL173547B1 (pl) 1998-03-31
CZ248995A3 (en) 1996-03-13
CA2156746A1 (en) 1994-10-13
FI954497L (fi) 1995-09-22
FI954497A0 (fi) 1995-09-22
YU14394A (sh) 1997-01-08
HU9502794D0 (en) 1995-11-28
EP0689458B1 (de) 1998-11-25
EP0689458A1 (de) 1996-01-03
IL109084A0 (en) 1994-06-24
SK120695A3 (en) 1997-02-05
IL109084A (en) 1996-12-05
US5686098A (en) 1997-11-11
ATE173636T1 (de) 1998-12-15
DE59407345D1 (de) 1999-01-07
AU681383B2 (en) 1997-08-28
DK0689458T3 (da) 1999-08-09
JPH08508266A (ja) 1996-09-03
NO953792L (no) 1995-09-25
DE4309830C1 (de) 1994-05-05
GR3029387T3 (en) 1999-05-28
KR960700754A (ko) 1996-02-24
AU6208394A (en) 1994-10-24
HRP940213A2 (en) 1998-02-28
NO953792D0 (no) 1995-09-25
HU220861B1 (en) 2002-06-29

Similar Documents

Publication Publication Date Title
EP0716615B1 (en) Low flux transdermal potent drug delivery system
SK280246B6 (sk) Náplasť s účinnou látkou na dávkovanie estradiolu
US9486417B2 (en) Transdermal therapeutic system for administering lipophilic and/or sparingly skin-permeable active substances
EP0836506B1 (en) Transdermal patch for administering 17-deacetyl norgestimate alone or in combination with an estrogen
RU2154455C2 (ru) Чрескожные терапевтические системы, содержащие половые стероиды
KR100628796B1 (ko) 에스트라디올과 다른 스테로이드를 함께 투여하기 위한 경피약물 송달기제
US6274165B1 (en) Transdermal, hormone-delivering therapeutic system
SK137995A3 (en) Transdermal therapeutic system containing estradiol
JPH07330609A (ja) エストロゲンおよび／またはプロゲストゲンを投与するのに用いるスチレン−イソプレン−スチレン共重合体ベースの経皮マトリックスシステム
SK279112B6 (sk) Spôsob výroby transdermálneho terapeutického systé
CA2049288A1 (en) Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
KR100297548B1 (ko) 덱스판텐올이함유된,스테로이드호르몬의경피적용을위한플라스터
US20060088580A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion
NZ502352A (en) Transdermal therapeutic system (TTS) for administering sexual steroid hormones
US7056528B1 (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
AU8805598A (en) Therapeutical system for transdermal delivery of levonorgestrel
SK40698A3 (en) Transdermal matrix system
SK281626B6 (sk) Transdermálny terapeutický systém s obsahom estradiolu
CA2410336A1 (en) Transdermal therapeutical system with a reduced tendency of the active substance to crystallize
KR950002749A (ko) 0차 흡수속도를 갖는 지속성 경피투여 제형 및 그 제조방법